Mayne Pharma Group logo
MYX

Mayne Pharma Group

Pharmaceuticals, Biotechnology & Life Sciences

Mayne Pharma Group Limited is a specialty pharmaceutical company listed on the ASX, focused on commercializing pharmaceuticals and improving patient access to life-enhancing medications. The company has a 40-year track record of innovation in developing oral drug delivery systems, offering a portfolio of branded and generic drugs in therapeutic areas like women's health and dermatology.

Short position

short percentage2.23%
reported shorts1.8M
shares on issue81.891M

Mayne Pharma Group (ASX:MYX) has 2.23% of its shares on issue reported as short positions as of 5 Oct 2026, or about 1,825,643 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has fallen 0.32 percentage points. Its highest recorded short interest was 13.53% in May 2017. MYX is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.

Price & short interest

Toggle series, zoom, and compare · ASIC daily, T+4

Mayne Pharma Group (MYX) short interest history

MYX Short Interest History

30-day change
-0.02pp
90-day change
-0.32pp
1-year change
+0.95pp
All-time high
13.53% (May 2017)
All-time low
0.00% (January 2011)

Is MYX heavily shorted?

Not especially: 2.23% short interest is modest by ASX standards, ranking #143 of 799 ASX securities with reported short positions. ASIC requires positions of 0.01% of issued capital or $100,000 (whichever is less) to be reported.

How has MYX's short interest changed recently?

Over the past 30 days Mayne Pharma Group's short interest has been broadly stable, and over 90 days it has been broadly stable. The current level is 2.23% of shares on issue.

What is the highest MYX's short interest has been?

Since 2011, Mayne Pharma Group's short interest peaked at 13.53% in May 2017 and bottomed at 0.00% in January 2011.

Where does this data come from?

All figures are sourced from daily ASIC short position reports, published with a four trading-day (T+4) delay. Shorted aggregates the full history since 2011. See our methodology.